Nwakanma Lois U, Simpkins Christopher E, Williams Jason A, Chang David C, Borja Marvin C, Conte John V, Shah Ashish S
Division of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, Md, USA.
J Thorac Cardiovasc Surg. 2007 Feb;133(2):541-7. doi: 10.1016/j.jtcvs.2006.09.062. Epub 2007 Jan 10.
Lung transplantation has been increasingly applied to patients over the age of 60 years. Importantly, the procedure of choice, single versus bilateral lung transplantation, remains unclear. Therefore, the purpose of this study was to examine short- and midterm outcomes in this age group with particular attention to procedure type.
All first lung transplant recipients, 60 years of age or older, reported to the United Network for Organ Sharing from 1998 to 2004 were divided into two groups: bilateral and single lung transplantation. A retrospective review of pertinent baseline characteristics, clinical parameters, and outcomes was performed. Kaplan-Meier methodology was used to estimate and Cox proportional hazards regression modeling was used to compare posttransplant survival between these groups. Additionally, propensity scores analysis was performed.
During the study period, 1656 lung transplant recipients were 60 years of age or older (mean 62.7 +/- 2.4 years, median 62 years). Of these, 364 (28%) had bilateral and 1292 (78%) had single lung transplantation. Survival was not statistically different between the two groups. In the multivariate analysis, bilateral versus single lung transplantation was not a predictor of mortality. Idiopathic pulmonary fibrosis and a donor tobacco history of more than 20 pack-years were significantly associated with mortality (P = .003, CI 1.12-1.76; and P = .006, CI 1.09-1.63; respectively).
The survival of lung transplant recipients 60 years of age or older who underwent bilateral versus single lung transplantation is comparable. These data suggest that type of procedure is not a predictor of mortality in this age group. Idiopathic pulmonary fibrosis and donor cigarette use of more than 20 pack-years were independently associated with mortality.
肺移植已越来越多地应用于60岁以上的患者。重要的是,选择何种手术方式,即单肺移植还是双肺移植,仍不明确。因此,本研究的目的是考察该年龄组患者的短期和中期预后,尤其关注手术方式类型。
将1998年至2004年向器官共享联合网络报告的所有60岁及以上的首例肺移植受者分为两组:双肺移植组和单肺移植组。对相关基线特征、临床参数和预后进行回顾性分析。采用Kaplan-Meier方法进行估计,并使用Cox比例风险回归模型比较两组移植后的生存率。此外,还进行了倾向得分分析。
在研究期间,1656例肺移植受者年龄在60岁及以上(平均62.7±2.4岁,中位数62岁)。其中,364例(28%)接受了双肺移植,1292例(78%)接受了单肺移植。两组的生存率在统计学上无差异。在多变量分析中,双肺移植与单肺移植并非死亡率的预测因素。特发性肺纤维化和供体吸烟史超过20包年与死亡率显著相关(分别为P = .003,CI 1.12 - 1.76;P = .006,CI 1.09 - 1.63)。
60岁及以上接受双肺移植与单肺移植的肺移植受者生存率相当。这些数据表明,手术方式类型并非该年龄组死亡率的预测因素。特发性肺纤维化和供体吸烟超过20包年与死亡率独立相关。